AN2 Therapeutics, Inc. (ANTX)

4.70 +0.10 (+2.17%) USD  |  NASDAQ  |  May 08, 14:18
More

AN2 Therapeutics Total Operating Expenses (TTM)

Total Operating Expenses (TTM) Chart

View Total Operating Expenses (TTM) for ANTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (TTM) Range, Past 5 Years

View Total Operating Expenses (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (TTM) Benchmarks

View Total Operating Expenses (TTM) Benchmarks
Start Trial
Relmada Therapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Savara, Inc. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade